fbpx

Sentinel Node Biopsy versus Axillary Clearance in Operable Breast Cancer – SNAC II

Sentinel Node Biopsy versus Axillary Clearance in Operable Breast Cancer – SNAC II

About this clinical trial

This study is comparing two operations, axillary  clearance and sentinel node biopsy, that detect cancer cells in the lymph nodes of women with early breast cancer.

Participants are currently being followed up so that long term effects of their treatment can be measured.

Patients Required

Estimated completion

Follow-up completed 2030

Total participants required

Closed to recruitment

Study location

The Wesley Hospital

Trial title

A multicentre randomised trial of sentinel node biopsy versus axillary clearance in operable breast cancer 

Eligibility

Inclusion criteria:

  1. Age >18 years
  2. Early stage breast cancer diagnosis

Additional information

You can find out more about the SNAC II trial by visiting the ANZCTR website.

Lead investigator

A/Prof Owen Ung

If you would like more information about this clinical trial, please complete the SNAC II contact form

Name(Required)
Address(Required)

Wesley Medical Research

Scroll to Top